Innovita Biological Technology Co., Ltd. (SHA:688253)
China · Delayed Price · Currency is CNY 56.03
+0.21 (0.38%)
At close: Aug 4, 2026
SHA:688253 Revenue
Innovita Biological Technology had revenue of 108.81M CNY in the quarter ending March 31, 2026, a decrease of -47.43%. This brings the company's revenue in the last twelve months to 323.87M, down -40.76% year-over-year. In the year 2025, Innovita Biological Technology had annual revenue of 422.03M, down -32.08%.
Revenue (ttm)
323.87M
Revenue Growth
-40.76%
P/S Ratio
23.33
Revenue / Employee
567.21K
Employees
571
Market Cap
7.56B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 422.03M | -199.36M | -32.08% |
| Dec 31, 2024 | 621.39M | 143.37M | 29.99% |
| Dec 31, 2023 | 478.02M | 31.40M | 7.03% |
| Dec 31, 2022 | 446.62M | 119.71M | 36.62% |
| Dec 31, 2021 | 326.91M | -710.19M | -68.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.